Helix Biopharma Corp
TSX:HBP

Watchlist Manager
Helix Biopharma Corp Logo
Helix Biopharma Corp
TSX:HBP
Watchlist
Price: 2.29 CAD 5.05% Market Closed
Market Cap: 174.9m CAD

Relative Value

There is not enough data to reliably calculate the relative value of HBP.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HBP Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.8
vs History
vs Industry
Median 3Y
-8.2
Median 5Y
-26.2
Industry
24.1
vs History
vs Industry
Median 3Y
-13.3
Median 5Y
-26.4
Industry
21.8
vs History
vs Industry
Median 3Y
-13.3
Median 5Y
-25.4
Industry
23.8
vs History
34
vs Industry
0
Median 3Y
-35.6
Median 5Y
-35.6
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
vs Industry
Median 3Y
-8.2
Median 5Y
-26.5
Industry
6.3
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-26.5
Industry
6.7
vs History
vs Industry
Median 3Y
-12.8
Median 5Y
-26.4
Industry
7.9
vs History
vs Industry
Median 3Y
-12.8
Median 5Y
-26.4
Industry
6.3
vs History
11
vs Industry
Median 3Y
-76
Median 5Y
-156
Industry
5.5

Multiples Across Competitors

HBP Competitors Multiples
Helix Biopharma Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Helix Biopharma Corp
TSX:HBP
174.9m CAD 0 -35.9 -37 -36.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 710 712 -160 222 -194 560.6 -192 340.5
US
Abbvie Inc
NYSE:ABBV
402.8B USD 6.8 171.5 16.6 23.5
US
Amgen Inc
NASDAQ:AMGN
178.3B USD 5 25.5 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD 5.3 19 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.9B USD 10 31.8 23.4 24.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 089.8 -533.3 -580.7 -565.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.1B USD 5.8 17.9 17.1 19.4
AU
CSL Ltd
ASX:CSL
85.5B AUD 3.7 19 12.8 16
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
53.7B USD 16.7 1 233.4 162.1 196.6
NL
argenx SE
XBRU:ARGX
44.4B EUR 14.5 34.1 58.8 60.4
P/S Multiple
Revenue Growth P/S to Growth
CA
Helix Biopharma Corp
TSX:HBP
Average P/S: 3 371 286.9
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 710 712
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.8
9%
0.8
US
Amgen Inc
NASDAQ:AMGN
5
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.3
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
10%
1
US
E
Epizyme Inc
F:EPE
2 089.8
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.8
6%
1
AU
CSL Ltd
ASX:CSL
3.7
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.7
46%
0.4
NL
argenx SE
XBRU:ARGX
14.5
49%
0.3
P/E Multiple
Earnings Growth PEG
CA
Helix Biopharma Corp
TSX:HBP
Average P/E: 194
Negative Multiple: -35.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 222 N/A N/A
US
Abbvie Inc
NYSE:ABBV
171.5
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
9%
2
AU
CSL Ltd
ASX:CSL
19
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 233.4
N/A N/A
NL
argenx SE
XBRU:ARGX
34.1
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Helix Biopharma Corp
TSX:HBP
Average EV/EBITDA: 40.2
Negative Multiple: -37
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 560.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
11%
1.6
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.1
N/A N/A
NL
argenx SE
XBRU:ARGX
58.8
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Helix Biopharma Corp
TSX:HBP
Average EV/EBIT: 46.4
Negative Multiple: -36.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 340.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.5
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
13%
1.5
AU
CSL Ltd
ASX:CSL
16
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
196.6
N/A N/A
NL
argenx SE
XBRU:ARGX
60.4
N/A N/A